Tempo Therapeutics

company

About

Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$255.99K
Industries
Health Care,Medical,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Tempo Therapeutics develops materials that are immune stealth, minimally invasive, and precision-engineered for regenerative medicine. It provides power to regenerative medicine, providing materials that evade the typical host immune rejection response to build synthetic tissue hybrids from skin to bone to heart to brain.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$255.99K
Tempo Therapeutics has raised a total of $255.99K in funding over 2 rounds. Their latest funding was raised on Sep 2, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 2, 2020 Grant $255.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Tempo Therapeutics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant